Skip to main content
Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma.
Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.
Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco.
Prognostic importance of p15INK4B and p16INK4 gene inactivation in childhood acute lymphocytic leukemia.
Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation.
Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group.
Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study.
Escalating dose of continuous infusion combination chemotherapy for refractory neuroblastoma.
Role of radiotherapy in neuroblastoma.
Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy.